Viewing Study NCT00358020


Ignite Creation Date: 2025-12-25 @ 4:07 AM
Ignite Modification Date: 2025-12-26 @ 3:04 AM
Study NCT ID: NCT00358020
Status: COMPLETED
Last Update Posted: 2006-12-04
First Post: 2006-07-27
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Melphalan, Prednisone, Thalidomide And Bortezomib In Advanced And Refractory Multiple Myeloma Patients
Sponsor: University of Turin, Italy
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module